INTERVIEW
The controversy continues to agitate the scientific community: what is really worth the study on hydroxychloroquine published in the journal The Lancet, on May 22, who pointed to an excess mortality of patients receiving this molecule? While this article has been widely criticized, even in the direction of the newspaper, a new study published Wednesday in the New England Journal of Medicine ((NEJM) concludes that hydroxychloroquine is ineffective in preventing coronavirus, explains on Europe 1 Frédéric Adnet, head of emergency at the Avicenne hospital in Bobigny.
The study of NEJM (to find here, in English) was carried out in “double-blind”, which means that “neither the doctor nor the patient knows the treatment which was allocated”. In this study, “there was one group who had a placebo, that is, no treatment, and the other who had hydroxychloroquine. It was a preventive treatment for patients at risk of d “have the virus because they have been exposed to sick people. The result of this test shows no difference. We are sure that for prevention, I mean prevention: hydroxychloroquine is useless. affirm it “, supports the specialist in the program Without an appointment with Mélanie Gomez.
“Very high level of evidence”
If Frédéric Adnet emphasizes the importance of this new study, it is because it comes from a “very high level of evidence” and is “unassailable in its methodology”: “The methodology makes it possible to make a link of cause and effect “, he explains, knowing that” none of the studies “has so far been” conclusive, except the one that has just come out “. “There have been 15,000 articles on the coronavirus but only ten randomized and prospective studies,” he insists.
While the WHO decided to resume clinical trials on hydroxychloroquine, the debate has now gone beyond the scientific field. “There is a great deal of confusion linked to the media coverage of this molecule, with announcements at the start that were not rational,” observed the head of emergency at the Bobigny hospital. “The study of Lancet was a bit catastrophic since it is not retracted but put in brackets “with a” warning “sent by the management of the newspaper.
Beyond the study methodology criticized by many scientists, Frédéric Adnet deplores the fact that this has slowed down research on the coronavirus: “The study of Lancet panicked our guardianship and, incomprehensibly, prevented us from continuing our tests on hydroxychloroquine. Even in clinical trials, the safety of the drugs is maximum. If there is a place where there is the least risk of side effects, it is in clinical trials because everything is hyper controlled, “insists the specialist.
–
